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Abstract Cigarette smokingis the dominantrisk factor forchronicobstructivepulmonarydisease (COPD).However,
only10^15% of smokers develop the disease and earlychangeswithin the airways are poorlyde¢ned.We aimed to com-
pare cell pro¢les in induced sputum (IS) from asymptomatic smokers to that from healthy subjects, and to ascertain
whetherornotin£ammatorycellsin IS arerelatedtolung functionandsmokinghabit.Werecruited 34 heavy, non-allergic
asymptomatic smokerswithnormallung functionand15 healthy volunteers,whoperformedlung functiontests and ISby
hypertonic saline (3%) solution.In smokers, signi¢cantcorrelationbetweenpack-years and FEF25^75 (rs=ÿ0?43,Po0?02)
was found. In IS, smokers had higher counts of macrophages (Po0?01) and eosinophils (Po0?02), when compared to
those of healthy subjects.Additionally, eosinophilswere foundin IS of14 outof 34 smokers, with eosinophils had ahigher
pack-years (31725 vs.13710, P=0?02) andlower FEF 25^75% value (78%734 vs.100%723, Po0?04), when compared to
smokers without eosinophils. Additionally, on the basis of regression equations by stepwise multiple regression analysis,
eosinophils were predicted by pack-years (r2=0?41). Our results showed that asymptomatic smokers have
evidence of in£ammatorycells in IS samples.In addition, we foundthatthe degree of eosinophilic in£ammationis related
to earlychanges of lung function and can be predicted by smokinghabit.r2001Harcourt Publishers Ltd
doi:10.1053/rmed.2001.1191, available online at http://www.idealibrary.comon
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Cigarette smoking is the dominant risk factor for
chronic obstructive pulmonary disease (COPD) (1,2).
However, only 10^15% of smokers develop the disease
(1) and early changes within the airways are poorly
de¢ned. A decrease in forced expiratory volume in1sec
(FEV1) and forced mid-expiratory £ow (FEF25^75) have
been recognized as early lung function changes in
smokers without COPD (3^6). In smokers with
chronic bronchitis the percentage of neutrophils in
bronchoalveolar lavage (BAL) is higher than in
asymptomatic smokers or the normal subjects (7). The
percentage of neutrophils in BAL correlated with the
number of pack-years, sputum production and airway
obstruction (7). In addition, smokers have a higher
number of alveolar macrophages from BAL £uid withReceived 26 February 2001, accepted in revised form6August 2001and
published online17 October 2001.
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compared to non-smokers (8). BAL £uid from COPD
patients is characterized by an increase in activated
lymphocytes (9), neutrophils (10), and macrophages (9),
as well as a mild degree of eosinophilia (11).
Induced sputum (IS), an alternative method to assess
airway in£ammation (12) has long been performed in
smoking individuals. The percentage of neutrophils in IS
from smokers with airway obstruction was higher than
that found in smokers without airway obstruction (13). In
addition, the percentage of neutrophils in IS correlated
with the decline in FEV1, assessed over a 15-year follow-
up period (13). The phenotype of sputum macrophages
was altered by chronic smoking (14), and the expression
of integrins on sputum polymorphonuclear leukocytes
was increased (15). It has been suggested that the
over-expression of integrins could represent a marker
for smokers who are more susceptible to develop
COPD (15).
The aim of this study was to compare cell pro¢les in IS
from asymptomatic smokers to IS from healthy subjects
and to ascertain whether or not in£ammatory cells in IS
are related to lung function and smoking habit.
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Subjects
We enrolled 34 (17 female, age range19^71years) heavy,
non-allergic smokers (2?5^80 pack-years) from our
outpatient clinic. Subjects had no history of chronic
hypersecretion, asthma, chronic bronchitis or any
allergic disease. The atopic status was also assessed by
blood eosinophil count and by skin prick tests. Blood
samples were obtained in all subjects and leukocyte
counts and standard di¡erential eosinophil counts were
estimated by a Coulter counter (Sysmex SE-9500, Toa,
Japan). We selected only subjects with normal percen-
tages of blood leukocytes and eosinophils. Skin prick
tests were performed by using a standard battery of
eight common airborne allergen extracts.
Moreover, all subjects did not have any bronchial or
respiratory tract infections during themonth preceding
the study. Baseline lung functional tests were within the
normal range (FEV1 value485% of predicted value and
FEV1/VC480%; changes in FEV1 20min after the
inhalation of 200mg salbutamol o12% as percentage of
predicted value).
As a control group, we included 15 healthy lifetime
non-smoking volunteers recruited from thehospital sta¡
(10 female, age range 21^70 years) who had experienced
no acute respiratory illness within the 4 weeks prior to
the study. All subjects deniedpersonal or family histories
of allergy or respiratory disease. Each subject gave
informed consent to study protocol.
Study protocol
Subjects were studied in the morning (between 08?00
and 10?00hours) and were asked not to smoke during
the preceding 12h. Lung function measurements and
induced sputumwere performed on the same day.
Lung function tests included measurement of vital
capacity (VC), FEV1 and FEF25^75 (Vmax 22, Sensor
Medics,Yorba Linda,U.S.A.).The normal reference values
were those proposed by The European Respiratory
Society (16). Sputum induction and processing were
carried out according to Fahy’s method (12), with slight
modi¢cations (17). All subjects inhaled 3% hypertonic
saline solution four times for 5min using an ultrasonic
nebulizer (Heyer Orion 1, BAD EMS; mean volume
output: 2?40mlminÿ1). Throughout the procedure,
subjects were encouraged to cough and to expectorate
into a plastic container.Three £ow volume curves were
performed before and after each inhalation and the best
FEV1 was recorded. Induction of sputum was stopped
if FEV1 value fell by at least 15% from baseline or if
troublesome symptoms occurred.
Sputum sample volume was measured and an equal
volume of dithiotreitol 0?1% was added and incubated at371C for 30min. Ten microlitres of the homogenized
sample were used to determine total cell counts and
results were expressed as number of cells105mlÿ1.
The remaining sputum was washed with phosphate-
bu¡ered saline and centrifuged at 2000 rpm for a 5-min
period. The supernatant was aspirated, and cell pellets
were re-suspended in saline (2000 rpm for 10min),
cytocentrifuged at 600 rpm for 10min and stained with
May^Grˇnwald^Giemsa. The percentage of macro-
phages, neutrophils, lymphocytes, eosinophils and
epithelial cells were counted on at least 400 cells,
excluding squamous cells. The IS samples were
considered adequate if salivary contamination were not
excessive (more than 80% of squamous epithelial cells).
Statistical analysis
The percentage of cells was reported as mean7SD. The
goodness of ¢t to the normal distribution was assessed
by Kolmogorov^Smirnov test. Smokers were grouped
in two subgroups, according to the presence of the
eosinophils, de¢nedby the count1on at least 400 cells
from IS. Di¡erences in numerical data between groups
were analysed by unpaired t-test or by Mann^Whitney
U-test, when appropriated. Di¡erences in qualitative
data were analysed by Fisher exact test. Relationships
were estimated by Spearman rank correlation
coe⁄cient (rs). Stepwise multiple regression analysis
was used to determine the best predictor variables
among age, packs/year, FEV1, VC, FEV1/VC, and FEF25^75
for the dependent variable eosinophils. Percentage of
total variance in the dependent variable, accounted for
by the predictors variables is expressed as the adjusted
square of the multiple correlation coe⁄cient (r2). To
avoid co-linearity, variables a¡ected by air£ow obstruc-
tion (for example FEV1, FEV1/VC, and FEF25^75 ) were
entered into the analysis separately. A P-value of less
than 0?05 was considered signi¢cant.
RESULTS
Characteristics of asymptomatic smokers and healthy
subjects are shown inTable1.No di¡erences were found
between smokers and healthy subjects in age, gender,
and in FEV1,VC, FEV1/VC, but not in FEF 25^75 values.
In smokers, the mean count of leukocytes (nmm3)
and themean percentage eosinophils fromblood sample
were 617071990 and 1.5%71, respectively. In these
subjects, a signi¢cant correlation between pack-years
and baseline FEF 25ÿ75 values (rs=ÿ0?43, Po0?02) was
also found.
The procedure for sputum induction was well
tolerated and adequate sputum samples were obtained
in all subjects.The total and di¡erential cell counts of IS
between smokers and healthy subjects are presented in
TABLE 1. Characteristics of the smokers and healthy
subjects
Smokers
(n=34)
Healthy subjects
(n=15)
Gender (M/F) 17/17 5/10
Age (yrs) 40714 38715
VC (% pred) 113718 108712
FEV1 (% pred) 110720 112713
FEF25^75 (%pred) 91730* 109718
FEV1/VC (%) 81710 85710
Pack-years (n) 21720 F
Values are expressed asmeans7SD.
*Po0?04, unpaired t-test.
FIG. 1. (a) Individual andmean values of number of pack-years
in 20 smokers without eosinophils in IS and in 14 smokers with
eosinophils in IS (Po0?02,Mann^Whitney U-test). (b) Individual
andmean values of FEF 25ÿ75 value in 20 smokers without eosi-
nophils in IS and in 14 smokers with eosinophils in IS (Po0?04,
unpaired t-test).
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(Po0?01) and eosinophils (Po0?02), when compared to
those of healthy subjects. Additionally, in smokers, no
correlationwas foundbetween blood and IS eosinophils.
Eosinophils were found in IS of 14 out of 34 smokers.
When smokers were grouped in two subgroups,
according to the presence of the eosinophils, smokers
with eosinophils had a higher pack-years (31725 vs.
13710, Po0?02) and lower FEF25^75% value (78%734 vs.
100%723,P=0?04), when compared to smokerswithout
eosinophils (Fig. 1). Moreover, in the former subgroup
FEV1 values were numerically but not statistically lower
than those of the latter subgroup (102%722 vs.
115%718) (Table 3).
The regression equation generated by stepwise
multiple regression analysis for eosinophils, as dependent
variable, includedpack-years, as themain predictor vari-
able: eosinophils (%)=0?13+0.12 (pack-years); (r2=0?41).
DISCUSSION
In this study, we showed that eosinophils can be present
in IS from asymptomatic smokers with normal lungTABLE 2. Totalcell anddi¡erentialcellcountininducedsputum
subjects
Total cells, n105mlÿ1 5?2
Squamous cells, n103mlÿ1 17
Macrophages, n103mlÿ1 25
Neutrophils, n103mlÿ1 9
Lymphocytes, n103mlÿ1
Eosinophils, n103mlÿ1
Values are expressed asmean (range).
*Po0?05,Mann^Whitney U-test.function.We also found that the presence of eosinophils
is strictly linked to early changes in lung function,
assessed by FEF25^75%, and can be predicted by smoking
habit.from 34 smokerswithnormallung functiontests and15 healthy
Smokers Healthy subjects
(1?0^25?6) 3?1 (0?9^8?2)
0 (0?3^740) 210 (50^600)
0 (3^1750)* 80 (3^170)
0 (0?1^870) 20 (0?1^110)
0?4 (0^50) 0?4 (0^10)
0?2 (0^20)* 0?02 (0^0?2)
TABLE 3. Characteristics of the smokers with eosino-
phils in the IS and the smokerswithouteosinophils in IS
Smokerswith
eosinophils
(n=14)
Smokerswithout
eosinophils
(n=20)
Gender (M/F) 10/7 7/13
Age (yrs) 44716 37712
VC (% pred) 111718 114718
FEV1 (% pred) 102722 115718
FEF25^75 (%pred) 78734* 100723
Pack-years (n) 31725w 13710
Values are expressed asmeans7SD.
*Po0?05, unpaired t-test; *Po0?05, Mann^Whitney U-
test.
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asymptomatic smokerswas signi¢cantly higher than that
from age and gender matched controls, even if it does
not di¡er when compared to that of large numbers of
normal subjects (18,19). However, the applicability of
these reference values to our study is limitedbothby dif-
ferent sputum induction protocol, particularly in terms
of di¡erenthypertonic saline concentration and duration
of inhalation, by di¡erentmethod of sputum processing,
and by di¡erent age ranges.The presence of eosinophils
in IS from smokers is not surprising. Keating and Barnes
(20) have detected an increased concentration of
eosinophil cationic protein (ECP) and of eosinophil
peroxidase (EPO) in IS from smokers with air£ow l
imitation. These ¢ndings suggest that eosinophils in
the airway of air£ow limited patients are actively
degranulating. In addition, it has been demonstrated that
the number of eosinophils in sputum and in bronchial
biopsies tends to increase during an exacerbation in
COPD patients (11). A possible role for eosinophils in
the airway in£ammation induced by smoking is also
supported by animal studies. Repeated exposure to
cigarette smoke may induce prolonged airway
in£ammation and airway hyper-responsiveness in
guinea-pigs. Compared to control animals, eosinophils
were observed frequently in the mucosa of the main
bronchi of cigarette smoke-exposed guinea-pigs (21).
Furthermore, in smokers with severe COPD and airway
obstruction, a signi¢cant improvement in FEV1after oral
prednisone is evident only in those patients with sputum
eosinophilia (43%) and treatment is associated with a
signi¢cant decrease in sputum eosinophilia and ECP
(22). Moreover, eosinophils in sputum were inversely
related to FEV1, FEV1/VC, and bronchial hyper-respon-
siveness, and directly related to clinical score (23). Also,
eosinophils in thebloodmightbe a risk factor for chronic
air-£ow limitation among adult non-smokers (24).
However, there is still some debate concerning thenumber and possible signi¢cance of eosinophils in the
airway of patients with COPD. In fact, although
airway eosinophilia has been found in COPD during
exacerbation (11), an increase in airway eosinophils in
patients with stable conditions has been found in some
studies (20,25), but not in others (26).This could be due,
at least in part, to the di¡erent criteria adopted for
patient inclusion.
In this study, smokers had a signi¢cantly higher
percentage of macrophages in their sputum samples
compared to those of controls.This ¢nding is consistent
to previous reports on induced sputum from smokers
(14,20) and could be likely due to a decreased clearance
ofmacrophages from the airways as well as an increased
recruitment of blood monocytes to the alveoli. In
contrast with previously reported data, we found no
association between neutrophils in sputum, airway
patency degree and smoking history. Previous observa-
tions have found that an increasednumber of neutrophils
in the sputumwas associated with the degree of airway
obstruction and with a more rapid decline in lung
function in smokers and ex-smokers (13). Moreover,
neutrophils percentages in the smokers with COPD
were signi¢cantly correlated with the degree of air£ow
limitation as expressed as percent of predicted FEV1
(23). In COPD patients and in asymptomatic smokers,
neutrophils were related to FEV1and FEV1/VC ratio (27).
Moreover, in the same study, signi¢cant correlations
were observed between neutrophils and eosinophils in
the induced sputum, suggesting an interplay between
these cells in chronic airway in£ammation due to smok-
ing habit (28). Additionally, in smokers with COPD,
the sputum concentration of IL-8, chemokine involved
in the migration and activation of neutrophils and
eosinophils, was signi¢cantly correlated with the
concentration of ECP and negatively correlated with
FEV1 and FEV1/VC (29). However, the concentration of
IL-8 did not di¡er signi¢cantly between the current
smokers and ex-smokers.These ¢ndings suggest that an
abstention from smoking does not alter the activation of
the airway in£ammation cycle (30). In fact, no signi¢cant
di¡erences in lung function, leukocyte di¡erential, or
metachromatic cell counts were observed between
current and ex-smokers or between subjects with and
without chronic expectoration. In addition, smokers
with airway obstruction tended to have more
neutrophils and fewermacrophages in sputum compared
with thosewith normal FEV1/VCratio (15).However, this
ratio did not re£ect the narrowing of the small airways.
Small airway disease was considered not only as early
disease, but also a ¢rst stage in a long process leading
eventually to chronic air£ow obstruction. Since early
disease cannot be detected by measuring FEV1 because
middle-aged smokers are at no evident risk of functional
deterioration if their FEV1/VC ratio is normal (31).Thus,
in our smokers, we considered FEF25^75 and saw that
EOSINOPHILS ININDUCEDSPUTUMFROMASYMPTOMATICSMOKERS 973there was a strict link between eosinophils, pack-years
and FEF25^75. Although neutrophils in BAL £uid and IS
correlated positively with pack-years (23) we did not
observe any other correlations with in£ammatory cells
in IS. A signi¢cant inverse correlation between the FEV1
and pack-years and signi¢cant correlation between the
FEV1and neutrophils in BAL £uid (31) and in IS (32) were
also observed. The di¡erences between our data and
those of other investigators is probably based on the
selection of the smokers, since previously observations
considered smokers with COPD. Our population also
included asymptomatic smokers without air£ow limita-
tion who might be considered as intermediate between
COPD and healthy status.
In conclusion, our results showed that in IS samples
from smokerswithoutchronic cough and expectoration,
there is evidence for the presence of in£ammatory cells
(macrophages and eosinophils). In addition, we found
that the percentage of IS eosinophlis can be predicted
by the smoking habit.Therefore, our study suggests that
IS can be a potential tool for de¢ning early cytological
changes in asymptomatic smokers.
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